Four vaccine candidates—two in the US, one in China, and one in the UK—have been approved for early testing in people. Many others are also following. Researchers look to messenger RNA encased in nanoparticles, DNA plasmids, molecular clamps, and other approaches as they rush to design a vaccine against the new coronavirus. Inovio to develop […]
Saliva Test for COVID-19 Approved for Emergency Use by FDA on 13 April 2020. Saliva testing will help with the global shortage of swabs, increase possibility of people testing, and reduce risk to collect samples by health care professionals. The saliva-based test requires saliva collection by subject spitting several times in a given plastic tube. […]
The COVID19 has taken the world by a stranglehold and the outbreak is causing significant disruptions in clinical research which is facing significant challenges. The process for conducting conventional clinical trials become difficult and risky at a time when the public is advised to shelter at home and healthcare facilities become overwhelmed with caring for […]
Whether people develop immunity to COVID19 after being infected once is a pressing question. It’s of particular interest to several research developing plasma therapies, whereby antibody-containing blood plasma is extracted from recovered patients and administered to patients to help them fight off the infection. In rhesus macaques, a longitudinal tracking of re-exposure after the disappeared […]
The fact that COVID-19 patients have lost their sense of smell or taste is interesting because, if the virus infects the nose, it would use the exact same neurons as in the mouse studies to enter the brain. SARS‐CoV2 causes epidemic pneumonia characterized by acute respiratory distress. This novel coronavirus is similar to SARS‐CoV in […]
Several studies were conducted to evaluate the presence of COVID-19 in the GI track and eliminated with stools. The first case report in the USA of COVID-19 was published in The New England journal of medicine (https://www.nejm.org/doi/full/10.1056/NEJMoa2001191). The report showed, as early as day seven of clinical symptoms, elimination of COVID-19 in the stools of […]
The first participant in a clinical safety trial for a COVID-19 vaccine conducted by the Kaiser Permanente Washington Health Research Institute in Seattle was given an experimental dose on March 16, reports the Associated Press. Testing will begin with 45 young, healthy volunteers with different doses of shots co-developed by NIH and Moderna INC. Inovio […]
How do viral genomes’ sequences from swabs taken from infected patients help you build a family tree of the virus? Random mutations in the SARS-CoV-2 pathogen’s genome help researchers track the spread and transmission of COVID-19, the disease it causes. Source: News & Opinion Articles | The Scientist Magazine®
Confirmed cases reported from each country so far. Data from cruise ship outbreaks not included. SOURCE: ECDC